Skip to main content
TOPICS
Videos
Podcasts
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
Fenom PRO
FDA clears Spirosure's Fenom Pro Asthma Monitor
By
Laura Lovett
|
02:50 pm |
February 25, 2019
The Fenom Pro Asthma Monitor will let clinicians measure the fraction of exhaled nitric oxide in their patient's breath.
Another $15M for Spirosure's respiratory analysis device
By
Dave Muoio
|
05:13 pm |
January 08, 2018